Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
megestrol (megace) (1 trial)
Anorexia (Phase 3)
Cachexia (Phase 3)
Pancreatic Neoplasms (Phase 3)
Wasting Syndrome (Phase 3)
Weight Loss (Phase 3)
Trials (1 total)
Trial APIs (1 total)